The FDA has granted accelerated approval to Bavencio (avelumab) for the treatment of metastatic Merkel cell carcinoma (MCC).
Indications: Bavencio is a programmed death ligand-1 blocking antibody indicated for the treatment of adults and pediatric patients 12 years and older with metastatic MCC.
Dosage and administration: Administer 10 mg/kg as an intravenous infusion over 60 minutes every 2 weeks.
Efficacy and safety: Approval is based on data from a single-arm trial of 88 patients with metastatic MCC who received Bavencio. One-third experienced complete or partial shrinkage of their tumors. The response lasted for more than 6 months in 86% percent of responding patients, and more than a year in 45%.
Side effects/risks: The most common adverse reactions are fatigue, musculoskeletal pain, diarrhea, nausea, infusion-related reaction, rash, decreased appetite, and peripheral edema.
FDA approves first treatment for rare form of skin cancer. [news release]. Silver Spring, MD: FDA March 23, 2017. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm548278.htm.... Accessed March 31, 2017.
Bavencio [package insert]. Rockland, MA: EMD Serono, Inc. 2017. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761049s000lbl.pdf. Accessed March 31, 2017.
This Week's Must Reads
Advanced Cancer Mortality Predictor Tested, J Oncol Pract; ePub 2017 Dec 5; Adelson, Lee, et al
Impact of Smoke-Free Laws on Lung Cancer Rates, Cancer; ePub 2017 Nov 28; Hahn, Rayens, et al
Racial Disparities in Prostate Cancer Treatment, J Oncol Pract; ePub 2017 Dec 1; Bickell, et al
Oncology PA Burnout, Career Satisfaction Assessed, J Oncol Pract; ePub 2017 Nov 30; Tetzlaff, et al
Improving Patient-Oncologist Shared Decisions, J Oncol Pract; ePub 2017 Nov 27; Tattersall
Must Reads in FDA Actions
Varubi Approved for Delayed Nausea and Vomiting, Tesaro news release; 2017 Oct 25
FDA Approves Keytruda for Advanced Gastric Ca, Merck news release; 2017 Sep 22
FDA Approves Opdivo for Hepatocellular Carcinoma, Bristol-Myers Squibb news release; 2017 Sep 22
New Indication for Somatuline Depot, Ipsen package insert; 2017 Sep
Verzenio Approved for Certain Breast Cancers, FDA news release; 2017 Sep 28